SWKH
Get informed when a big investor buys or sells
+ FollowUndervalued by 69.8% based on the discounted cash flow analysis.
| Market cap | $305.42 Million |
|---|---|
| Enterprise Value | $294.77 Million |
| Dividend Yield | $4.00 (-) |
| Earnings per Share | $-0.21 |
| Beta | 0.3 |
| Outstanding Shares | 12,162,000 |
| P/E Ratio | -76.34 |
|---|---|
| PEG | 17.75 |
| Price to Sales | 5.3 |
| Price to Book Ratio | 0.84 |
| Enterprise Value to Revenue | 7.23 |
| Enterprise Value to EBIT | 11.83 |
| Enterprise Value to Net Income | -117 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.14 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 86.91%▲ 0.27% |
|---|---|
| Total Invested | $179.80M▼ 0.43% |
| Investors Holding | 590% |
No data
swk holdings corporation is focused on becoming a market leading innovator in healthcare finance by providing capital to a broad range of life science companies, institutions and inventors. swk’s primary focus is on monetizing cash flow ...